Phospho-CASP9 (S144) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide.
Form
Liquid
Lead Time
Generally, we can dispatch the products within 1-3 business days after receiving your orders. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery timeframes.
Synonyms
APAF-3 antibody; Apoptotic protease Mch-6 antibody; Apoptotic protease-activating factor 3 antibody; CASP-9 antibody; CASP9 antibody; CASP9_HUMAN antibody; Caspase 9 antibody; Caspase-9 subunit p10 antibody; ICE-LAP6 antibody; ICE-like apoptotic protease 6 antibody
Target Names
Uniprot No.

Target Background

Function
Caspase-9 plays a pivotal role in the activation cascade of caspases responsible for executing apoptosis. Binding of caspase-9 to Apaf-1 triggers the activation of this protease, which then cleaves and activates caspase-3. Caspase-9 promotes DNA damage-induced apoptosis in a manner dependent on ABL1/c-Abl. It proteolytically cleaves poly(ADP-ribose) polymerase (PARP). Isoform 2, lacking activity, acts as a dominant-negative inhibitor of caspase-9.
Gene References Into Functions
  • CASP9 mutations are associated with recurrent folate-resistant neural tube defects. PMID: 29358613
  • A study identified rare mutations in the CASP9 gene in neural tube defect cases. The identified p.Y251C variant impairs the protein's apoptotic function, suggesting it is a loss-of-function variation. The study also demonstrated that the p.R191G variant inhibits apoptosis under folate-deficient conditions, highlighting the significance of gene-environment interactions in this complex disease. PMID: 29365368
  • Research findings indicate that caspase-9 and activated caspase-3 predominantly regulate cell apoptosis in human dental pulp stem cells derived from deciduous teeth. PMID: 29845240
  • Low CASP9 expression is correlated with Colorectal Cancer. PMID: 29801534
  • Studies suggest that miR-96-5p, frequently upregulated in hepatocellular carcinoma (HCC), inhibits apoptosis by targeting CASP9. This finding indicates that miR-96-5p could potentially serve as a therapeutic target for HCC. PMID: 29658604
  • CASP9 germline mutations may have played a role in the susceptibility of developing gliomas in a Li-Fraumeni-like family without a TP53 germline mutation. PMID: 27935156
  • The caspase-9 level was significantly lower and correlated with oxidant status in patients with polycystic ovary syndrome, while the circulating levels of caspases 3 and 7 were statistically similar in both PCOS and control groups. PMID: 27899026
  • Results indicate that the apoptotic protease-activating factor 1 (Apaf-1) apoptosome activates caspase-9, partially through sequestration of the inhibitory caspase recruitment domains (CARDs) domain. PMID: 28143931
  • DES1 plays a crucial role in palmitic acid-mediated caspase-9 and caspase-3 activation. PMID: 27364952
  • CASP9 expression is associated with inhibition of miR-182. PMID: 28298075
  • CASP-9 polymorphism is associated with Primary Brain Tumors. PMID: 28870924
  • High CASP9 expression is linked to Lung Tumorigenesis. PMID: 27197231
  • Knockdown of HMGI-C resulted in the significant induction of apoptosis via the mitochondrial pathway by inducing miR34a and cell cycle arrest in MDA-MB-468 cells in vitro. PMID: 27245202
  • Results suggest that the formation of the apoptosome accompanied by the activation of caspase-9 may occur in brains affected by multiple system atrophy (MSA), and that a mitochondria-dependent apoptotic pathway may be partially involved in the pathogenesis of MSA. PMID: 27345387
  • Using recombinant proteins, this study investigated the influence of survivin on the inhibition of caspase-9 by XIAP in vitro. Utilizing a fluorescence-based assay for the apoptosome-stimulated activity of caspase-9, the study demonstrates that survivin has no effect on the inhibition of caspase-9 by XIAP, regardless of the presence or absence of Smac. PMID: 27865841
  • Data show that caspase-9 (CASP9) single nucleotide polymorphism (rs1052576) TT genotype appears to be associated with a higher risk of pathological stage. PMID: 28358701
  • The content of caspase-9 gene transcripts in peripheral blood leukocytes and plasma levels of TNF-alpha were significantly higher in healthy subjects carrying the C allele compared to carriers of the GG genotype. PMID: 28091912
  • Results demonstrate that mRNA and protein levels of HAX-1 in prostate cancer cell lines were significantly higher and inhibit cell apoptosis through caspase-9 inactivation. PMID: 26323553
  • Renal CASP9 expression is increased in diabetes and further increases as diabetic nephropathy progresses. PMID: 27141571
  • Inhibition of Caspase-9 restricted, while Apaf-1 promoted, Chlamydia pneumoniae infection in HEp-2, HeLa, and mouse epithelial fibroblast (MEF) cells. PMID: 26290316
  • Levels of caspase-9, caspase-10, MAVS, and pIRF7 in mononuclear cells and the disease activity index (SLEDAI) in systemic lupus erythematosus patients were determined. PMID: 25370148
  • Expression of mutant caspase-9 correlated with a downregulation of BAFFR (B-cell-activating factor belonging to the TNF family (BAFF) receptor) in B cells and ICOS (inducible T-cell costimulator) in T cells. PMID: 25569260
  • Caspase-9 mediates Puma activation to determine the threshold for overcoming chemoresistance in cancer cells. PMID: 25356864
  • Phosphorylation of caspase-9 may be a valuable tool for assessing the state of gastrointestinal cancer and the effects of anti-cancer therapy. PMID: 25031754
  • DNA fragmentation, DNA damage, caspase-9 activation, and a substantial increase in the sub-G1 and S cell cycle phases confirmed the occurrence of apoptosis in a time-dependent manner. PMID: 24377517
  • Data indicate a significant association of two single nucleotide polymorphisms (SNPs) in caspase-9 (CASP9) and two haplotypes of the four SNP combinations with acute myeloid leukemia (AML) susceptibility. PMID: 24879622
  • Silica and double-stranded RNA (dsRNA) synergistically induce caspase-9-dependent apoptosis, but not inflammasome activation, of bronchial epithelial cells. PMID: 24661197
  • KAT5 RNAi may result in cleaved caspase-9 upregulation through p38MAPK activation in gallbladder carcinoma cells. PMID: 24427328
  • Overexpression of iASPP and low expression of caspase-9 in esophageal cancer are strongly correlated with tumor invasion and metastasis. PMID: 24405603
  • The Atg7.caspase-9 complex has a dual function of linking caspase-9 to the autophagic process while simultaneously controlling its apoptotic activity. PMID: 24362031
  • The inhibitory effect of Ab42 on the apoptotic pathway is associated with its interaction with procaspase-9 and subsequent inhibition of Apaf-1 apoptosome assembly. PMID: 24424093
  • The rs4645981 T allele and the rs4645981 T allele carrier might increase the risk of cancer, but the rs1052576 A allele, rs1052576 A carrier, rs2308941 T allele, and rs2308941 T carrier might be protective. PMID: 23479167
  • Interactions of caspase-9 with the BIR3 (baculovirus inhibitory repeat 3) exosite are crucial for high-affinity binding. PMID: 23203690
  • In oligozoospermia, spermatogonia exhibited a significant increase in active caspase-9. PMID: 23359247
  • The change in caspase-9 expression from colon mucosa, adenoma to cancer suggests its potential involvement in the carcinogenesis of colon cancer. PMID: 24592539
  • dCas9 effectors can exert positive or negative regulation on the expression of developmentally relevant genes, influencing cell differentiation status when affecting a key node in the regulatory network that governs the cell state. PMID: 24346702
  • BIRC5-31CC and CASP9+83CT/TT genotypes were associated with an increased risk for renal cell carcinoma development in the female population of a southern European study. PMID: 23645041
  • OSU-03012 induces apoptosis in human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway. PMID: 23652278
  • EGCG, both alone and in combination with cisplatin, promoted the expression of the pro-apoptotic splice isoform of caspase-9. PMID: 23615977
  • Results demonstrated that 50 microg/mL beta-glucan significantly repressed the expression of the ERCC5 gene, had no effect on CASP9 expression, and induced the CYP1A1 gene. PMID: 23424205
  • CASP-9 polymorphisms are associated with susceptibility to low back pain during military training in Chinese soldiers. PMID: 23725396
  • Results suggest that polymorphisms of CASP9 and CASP10 genes may not contribute to CRC risk in the Chinese population. PMID: 23303631
  • Proteolytic processing of the caspase-9 zymogen is required for apoptosome-mediated activation of caspase-9. PMID: 23572523
  • Polymorphism in Caspase-9 (-1263 A>G) was observed to be associated with the susceptibility of papillary thyroid carcinoma (PTC). PMID: 22120515
  • Induction of caspase-9b expression is due to activation of hnRNP L via phosphorylation to compete/inhibit hnRNP U association with exon 3 of Casp9 mRNA. PMID: 23396972
  • These results clearly indicated that olive oil phenolic extract and gallic acid were able to inhibit the caspase-9 dependent apoptosis pathway in HeLa cells. PMID: 22086301
  • The overexpression of c-Jun, p73, and Casp-9 in thymic epithelial tumors is closely related to the pathogenesis and biological behavior of these neoplasms. PMID: 22974165
  • Data suggest that CD95L-triggered endogenous ceramide increase in Jurkat leukemia T cells is likely involved in the pro-apoptotic mitochondrial pathway leading to caspase-9 activation. PMID: 22306364
  • Caspase-9 is the most important regulator in DLD-1, HCT-116, and HeLa cells. PMID: 23038270
  • CASP9 promoter polymorphisms rs4645978 and rs4645981 are associated with breast cancer susceptibility. CASP9 transcriptional regulation is a crucial factor during breast cancer development. PMID: 22981751
Database Links

HGNC: 1511

OMIM: 602234

KEGG: hsa:842

STRING: 9606.ENSP00000330237

UniGene: Hs.329502

Protein Families
Peptidase C14A family
Tissue Specificity
Ubiquitous, with highest expression in the heart, moderate expression in liver, skeletal muscle, and pancreas. Low levels in all other tissues. Within the heart, specifically expressed in myocytes.

Q&A

Basic Research Questions

  • What is Phospho-CASP9 (S144) Antibody and how does it function in experimental contexts?

Phospho-CASP9 (S144) antibody is a polyclonal antibody specifically designed to detect endogenous levels of caspase-9 protein only when phosphorylated at Serine 144. This antibody is typically developed by immunizing rabbits with synthetic phosphopeptides derived from human CASP9 surrounding the Ser144 phosphorylation site . The antibody functions through specific epitope recognition, binding exclusively to the phosphorylated form while showing no reactivity with the non-phosphorylated protein. This specificity makes it an invaluable tool for studying post-translational modifications that regulate apoptotic pathways .

  • What are the validated applications for Phospho-CASP9 (S144) Antibody?

The Phospho-CASP9 (S144) antibody has been validated for multiple research applications with specific working dilutions:

ApplicationRecommended DilutionNotes
Western Blot (WB)1:500-1:2000Most commonly validated application across vendors
Immunohistochemistry (IHC)1:100-1:300For paraffin-embedded sections
Immunofluorescence (IF/ICC)1:50-1:200For cellular localization studies
ELISA1:20000For quantitative detection

These applications have been validated with human samples, with some antibodies also demonstrating reactivity with mouse and rat samples . Western blot analysis has confirmed detection in multiple cell lines including HEK293T, HepG2, and A375 whole cell lysates at approximately 47 kDa .

  • How should Phospho-CASP9 (S144) Antibody be properly stored and handled?

Proper storage and handling are critical for maintaining antibody functionality:

  • Short-term storage: 4°C (up to several weeks)

  • Long-term storage: -20°C (stable for approximately one year after receipt)

  • Aliquoting is essential to avoid repeated freeze-thaw cycles which can degrade antibody performance

  • Typical storage buffer composition: PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

  • Working dilutions should be prepared fresh before use

Following these guidelines ensures optimal antibody performance and specificity while preventing degradation that could compromise experimental results .

  • What is the molecular function of Caspase-9 and its role in the apoptotic pathway?

Caspase-9 (CASP9) is a critical initiator caspase in the intrinsic (mitochondrial) apoptotic pathway. The functional mechanism involves:

  • Initial form: 47 kDa procaspase-9 zymogen with minimal activity

  • Activation trigger: Cytochrome c release from mitochondria following apoptotic stimuli

  • Complex formation: Procaspase-9 associates with Apaf-1 (Apoptotic protease-activating factor 1) to form the apoptosome

  • Proteolytic processing: Cleavage occurs at Asp315, producing a p35 subunit

  • Secondary cleavage: Further processing at Asp330 produces a p37 subunit that amplifies the apoptotic response

  • Effector activation: Cleaved caspase-9 processes downstream caspases (primarily caspase-3 and caspase-7)

  • Outcome: Initiation of the caspase cascade leading to cellular apoptosis

This pathway represents a fundamental mechanism for programmed cell death that removes damaged or unnecessary cells during development and tissue homeostasis .

Intermediate Research Questions

  • How does phosphorylation at Serine 144 regulate Caspase-9 function?

Phosphorylation at Serine 144 serves as an inhibitory regulatory mechanism for Caspase-9:

  • Functional effect: Inhibits caspase-9 activation and subsequent caspase-3 activation

  • Cellular outcome: Restrains the intrinsic apoptotic pathway, promoting cell survival

  • Experimental validation: Prevention of Ser144 phosphorylation (through PKCζ inhibition or caspase-9 mutation) promotes caspase-3 activation and apoptosis

  • Specificity: This phosphorylation represents a distinct regulatory mechanism from other known phosphorylation sites on caspase-9

  • Structural implications: Likely alters protein conformation to prevent proper apoptosome formation or substrate interaction

This post-translational modification represents one of several mechanisms by which survival signaling pathways can impinge on the apoptotic machinery to maintain cellular viability during specific stress conditions .

  • Which kinases phosphorylate Caspase-9 at Serine 144 and under what conditions?

The primary kinase responsible for phosphorylating Caspase-9 at Serine 144 is protein kinase C zeta (PKCζ):

  • Kinase identification: Determined through inhibitor sensitivity profiles and direct protein-protein interaction studies

  • Kinase classification: PKCζ belongs to the atypical PKC subfamily (insensitive to both diacylglycerol and Ca²⁺)

  • Activation conditions:

    • Treatment with protein phosphatase inhibitors (e.g., okadaic acid)

    • Hyperosmotic stress (specifically activates PKCζ)

  • Selectivity: Phosphorylation at Ser144 is not induced by growth factors, phorbol esters, or other cellular stresses

  • Functional context: Part of the survival response during hyperosmotic challenge

This specific kinase-substrate relationship provides a mechanistic link between osmotic stress response pathways and apoptotic regulation .

  • How can researchers induce and detect Caspase-9 phosphorylation at Ser144 in experimental systems?

To effectively study Ser144 phosphorylation, researchers can employ several experimental strategies:

Induction methods:

  • Treat cells with okadaic acid (protein phosphatase inhibitor)

  • Subject cells to hyperosmotic stress conditions

  • Express constitutively active PKCζ constructs

Detection methods:

  • Western blotting with Phospho-CASP9 (S144) antibody (1:500-1:2000 dilution)

  • Immunofluorescence to visualize cellular localization (1:50-1:200 dilution)

  • Immunohistochemistry for tissue sections (1:100-1:300 dilution)

Controls for validation:

  • Use PKCζ inhibitors as negative controls

  • Employ S144A mutant caspase-9 (non-phosphorylatable) for specificity validation

  • Include both phosphorylated and non-phosphorylated samples to confirm antibody specificity

These methodological approaches enable systematic investigation of this regulatory mechanism in diverse experimental contexts .

  • How does Caspase-9 phosphorylation at Ser144 compare with other known phosphorylation sites?

Caspase-9 is one of the most extensively phosphorylated caspases, with at least 11 distinct phosphorylation sites across all domains. Key comparative insights include:

Phosphorylation SiteKinase(s)Functional EffectPhysiological Context
Ser144PKCζInhibitoryHyperosmotic stress response
Thr125ERK, CDK1InhibitoryCancer progression, mitotic regulation
Ser196Unknown*Not fully characterizedDetected with specific antibodies
Tyr153ABL1/c-AblRegulatoryDNA damage response

*While specific kinases for Ser196 weren't identified in the search results, commercial antibodies target this site .

Caspase-9 thus serves as a focal point for multiple protein kinase signaling pathways that regulate apoptosis, with each phosphorylation site potentially integrating different cellular signals .

Advanced Research Questions

  • What are the mechanistic differences between Ser144 phosphorylation and other inhibitory modifications of Caspase-9?

The inhibitory phosphorylation of Caspase-9 at different sites represents distinct regulatory mechanisms with specific physiological contexts:

  • Ser144 phosphorylation by PKCζ:

    • Specifically induced by hyperosmotic stress

    • Not responsive to growth factors or phorbol esters

    • Represents a targeted stress-response mechanism

    • Appears linked to cellular volume regulation pathways

  • Thr125 phosphorylation by ERK:

    • Regulated by growth factor signaling pathways

    • Commonly upregulated in cancer cells

    • May contribute to apoptotic resistance in tumors

    • Integrated with proliferative signaling networks

  • Thr125 phosphorylation by CDK1:

    • Cell cycle-dependent regulation

    • Specifically functions during mitosis

    • Prevents inappropriate apoptosis during cell division

    • Coordinated with cell cycle progression

These mechanistic differences illustrate how multiple signaling pathways converge on Caspase-9 to integrate diverse cellular conditions into a coherent apoptotic decision .

  • What experimental controls are essential when using Phospho-CASP9 (S144) antibody in complex experimental systems?

Robust experimental design with appropriate controls is critical when using phospho-specific antibodies:

Positive Controls:

  • Cells treated with okadaic acid

  • Cells subjected to hyperosmotic stress

  • Lysates from cells overexpressing constitutively active PKCζ

Negative Controls:

  • Samples treated with λ-phosphatase to remove all phosphorylations

  • Cells expressing S144A mutant caspase-9 (cannot be phosphorylated)

  • Samples from cells treated with PKCζ inhibitors

Specificity Controls:

  • Peptide competition assays (phosphorylated vs. non-phosphorylated peptides)

  • Dual labeling with total CASP9 antibody to normalize signals

  • CASP9 knockdown/knockout cells to confirm signal specificity

Application-Specific Controls:

  • For Western blots: Include molecular weight markers (expect ~47 kDa band)

  • For IHC/IF: Include isotype control antibodies

  • For quantitative applications: Generate standard curves with known quantities of phosphorylated protein

These controls ensure that observed signals truly represent Ser144 phosphorylation status rather than experimental artifacts .

  • How can Phospho-CASP9 (S144) antibody be incorporated into multi-parameter apoptosis studies?

For comprehensive apoptosis research, Phospho-CASP9 (S144) antibody can be integrated into multi-parameter studies:

Sequential activation analysis:

  • Combine with antibodies detecting total CASP9, cleaved CASP9 (Asp315), cleaved CASP3, and PARP cleavage

  • Create temporal profiles of phosphorylation status relative to cleavage events

  • Correlate phosphorylation with inhibition of downstream apoptotic events

Pathway integration studies:

  • Pair with analysis of PKCζ activation (phospho-PKCζ detection)

  • Include markers for mitochondrial outer membrane permeabilization

  • Measure cytochrome c release in parallel with caspase phosphorylation

Single-cell analysis approaches:

  • Multiplex immunofluorescence to correlate CASP9 phosphorylation with other apoptotic markers

  • Flow cytometry to quantify phospho/total CASP9 ratios across different cell populations

  • Live-cell imaging with appropriate reporters to track phosphorylation dynamics

Stress-response profiling:

  • Compare phosphorylation patterns across different stress conditions

  • Correlate with cell survival metrics and recovery capacity

  • Examine temporal dynamics of phosphorylation/dephosphorylation cycles

These approaches provide mechanistic insight into how phosphorylation regulates apoptotic execution in diverse physiological contexts .

  • What are the implications of Caspase-9 Ser144 phosphorylation for cancer research and therapeutic development?

Phosphorylation of Caspase-9 at Ser144 has significant implications for cancer biology and therapy:

Cancer resistance mechanisms:

  • Increased Ser144 phosphorylation may contribute to apoptotic resistance in tumor cells

  • PKCζ dysregulation could represent an unrecognized mechanism of therapy evasion

  • Monitoring phosphorylation status could potentially predict treatment response

Therapeutic targeting opportunities:

  • PKCζ inhibitors might sensitize resistant tumors to apoptosis-inducing therapies

  • Combination approaches targeting multiple phosphorylation sites could overcome compensatory mechanisms

  • Development of compounds that specifically block the interaction between PKCζ and Caspase-9

Biomarker development:

  • Phospho-CASP9 (S144) levels could serve as indicators of specific resistance mechanisms

  • Ratio of phosphorylated to total CASP9 might predict therapeutic vulnerability

  • Changes in phosphorylation status during treatment could indicate adaptive responses

Research applications:

  • Screening for compounds that modulate Ser144 phosphorylation

  • Understanding the relationship between osmotic stress and apoptotic regulation in tumor microenvironments

  • Identifying patient subgroups that might benefit from PKCζ-targeting approaches

These research directions highlight the potential translational significance of this phosphorylation site in cancer treatment strategies .

  • How does osmotic stress regulate the PKCζ-mediated phosphorylation of Caspase-9?

The mechanism connecting hyperosmotic stress to Caspase-9 phosphorylation involves several coordinated steps:

Stress sensing pathway:

  • Hyperosmotic conditions trigger cellular volume changes

  • Osmosensors (likely membrane proteins) detect these alterations

  • Signal transduction cascades activate PKCζ through mechanisms distinct from classical PKC activation

PKCζ activation mechanism:

  • Unlike conventional PKCs, PKCζ is insensitive to Ca²⁺ and diacylglycerol

  • Activation likely involves protein-protein interactions and/or phosphorylation events

  • Activated PKCζ specifically interacts with Caspase-9, as demonstrated by co-immunoprecipitation studies

Kinase-substrate interaction:

  • Activated PKCζ binds to Caspase-9

  • Phosphorylation occurs specifically at Ser144

  • This modification prevents Caspase-9 activation

  • The apoptotic pathway is restrained during osmotic adaptation

Pathway specificity:

  • Other cellular stresses (oxidative, genotoxic, ER stress) do not trigger this phosphorylation

  • Growth factors and phorbol esters (which activate other PKC isoforms) do not induce Ser144 phosphorylation

  • This represents a highly specific stress-response mechanism

Understanding this pathway provides insight into how cells maintain survival during osmotic challenges frequently encountered in physiological contexts .

  • What methodological approaches can be used to study the dynamics of Caspase-9 phosphorylation in live cells?

While standard phospho-antibodies cannot be used in live cells, several advanced approaches can be employed to study phosphorylation dynamics:

Genetically encoded biosensors:

  • Design FRET-based reporters incorporating the Ser144 region of Caspase-9

  • Changes in FRET signal occur upon phosphorylation/dephosphorylation

  • Enables real-time visualization of phosphorylation status

Engineered expression systems:

  • Create cell lines stably expressing fluorescently-tagged wild-type and S144A Caspase-9

  • Compare localization and protein interaction dynamics

  • Measure differential apoptotic responses to stimuli

Temporal analysis:

  • Conduct time-course experiments with fixation and immunostaining

  • Generate kinetic profiles of phosphorylation under different conditions

  • Correlate with other cellular events (e.g., PKCζ activation, apoptosis markers)

Advanced microscopy:

  • Apply techniques like fluorescence correlation spectroscopy to study molecular interactions

  • Use super-resolution microscopy to examine spatial organization of signaling complexes

  • Implement light-sheet microscopy for extended live imaging with reduced phototoxicity

These approaches enable researchers to move beyond static snapshots toward understanding the dynamic regulation of Caspase-9 in intact cellular systems .

  • How can phosphorylation of Caspase-9 at multiple sites be integrated into systems biology models of apoptosis?

Integrating multiple phosphorylation events into systems biology models requires sophisticated approaches:

Quantitative phosphoproteomics:

  • Measure absolute stoichiometry of phosphorylation at each site

  • Determine site occupancy under different conditions

  • Establish temporal relationships between modifications

Mathematical modeling:

  • Develop differential equation models incorporating phosphorylation/dephosphorylation kinetics

  • Include kinase activities, phosphatase actions, and downstream effects

  • Simulate interaction between multiple regulatory sites

Network integration:

  • Map connections between upstream signaling pathways and individual phosphorylation sites

  • Model crosstalk and feedback mechanisms between survival and apoptotic pathways

  • Predict cellular outcomes based on phosphorylation patterns

Experimental validation:

  • Generate phosphomimetic and phospho-null mutations at multiple sites

  • Conduct epistasis experiments to determine hierarchy of modifications

  • Apply optogenetic approaches to achieve temporal control over specific kinases

Translational applications:

  • Predict therapeutic vulnerabilities based on phosphorylation profiles

  • Design rational drug combinations targeting multiple regulatory nodes

  • Develop personalized treatment approaches based on patient-specific phosphorylation patterns

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.